SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Borch Kristin B.))
 

Sökning: (WFRF:(Borch Kristin B.)) > Association of Medi...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00011999naa a2200781 4500
001oai:DiVA.org:umu-212072
003SwePub
008230718s2023 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2120722 URI
0247 a https://doi.org/10.1186/s12916-023-02934-32 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Castro-Espin, Carlotau Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain4 aut
2451 0a Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries :b results from the EPIC cohort study
264 1b BioMed Central (BMC),c 2023
338 a electronic2 rdacarrier
520 a Background: The Mediterranean diet has been associated with lower risk of breast cancer (BC) but evidence from prospective studies on the role of Mediterranean diet on BC survival remains sparse and conflicting. We aimed to investigate whether adherence to Mediterranean diet prior to diagnosis is associated with overall and BC-specific mortality.Methods: A total of 13,270 incident breast cancer cases were identified from an initial sample of 318,686 women in 9 countries from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Adherence to Mediterranean diet was estimated through the adapted relative Mediterranean diet (arMED), a 16-point score that includes 8 key components of the Mediterranean diet and excludes alcohol. The degree of adherence to arMED was classified as low (score 0–5), medium (score 6–8), and high (score 9–16). Multivariable Cox proportional hazards models were used to analyze the association between the arMED score and overall mortality, and Fine-Gray competing risks models were applied for BC-specific mortality.Results: After a mean follow-up of 8.6 years from diagnosis, 2340 women died, including 1475 from breast cancer. Among all BC survivors, low compared to medium adherence to arMED score was associated with a 13% higher risk of all-cause mortality (HR 1.13, 95%CI 1.01–1.26). High compared to medium adherence to arMED showed a non-statistically significant association (HR 0.94; 95% CI 0.84–1.05). With no statistically significant departures from linearity, on a continuous scale, a 3-unit increase in the arMED score was associated with an 8% reduced risk of overall mortality (HR3-unit 0.92, 95% CI: 0.87–0.97). This result sustained when restricted to postmenopausal women and was stronger among metastatic BC cases (HR3-unit 0.81, 95% CI: 0.72–0.91).Conclusions: Consuming a Mediterranean diet before BC diagnosis may improve long-term prognosis, particularly after menopause and in cases of metastatic breast cancer. Well-designed dietary interventions are needed to confirm these findings and define specific dietary recommendations.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng
653 a Breast cancer
653 a Cancer survivors
653 a Dietary patterns
653 a Mediterranean diet
653 a Prospective studies
7001 a Bonet, Catalinau Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain4 aut
7001 a Crous-Bou, Martau Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain; Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States4 aut
7001 a Nadal-Zaragoza, Núriau Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain4 aut
7001 a Tjønneland, Anneu The Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Public Health, The University of Copenhagen, Copenhagen, Denmark4 aut
7001 a Mellemkjær, Leneu The Danish Cancer Society Research Center, Copenhagen, Denmark4 aut
7001 a Hajji-Louati, Mariemu Université Paris-Saclay, UVSQ, Inserm “Exposome, Heredity, Cancer and Health” Team, CESP U1018, Gustave Roussy, Villejuif, France4 aut
7001 a Truong, Thérèseu Université Paris-Saclay, UVSQ, Inserm “Exposome, Heredity, Cancer and Health” Team, CESP U1018, Gustave Roussy, Villejuif, France4 aut
7001 a Katzke, Verenau German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
7001 a Le Cornet, Charlotteu German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
7001 a Schulze, Matthias B.u Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany4 aut
7001 a Jannasch, Franziskau Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany4 aut
7001 a Masala, Giovannau Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy4 aut
7001 a Sieri, Sabinau Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Via Venezian, 1. 20133, Milan, Italy4 aut
7001 a Panico, Salvatoreu Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy4 aut
7001 a Di Girolamo, Chiarau Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, TO, Orbassano, Italy4 aut
7001 a Skeie, Guriu Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway4 aut
7001 a Borch, Kristin Benjaminsenu Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway4 aut
7001 a Olsen, Karina Standahlu Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway4 aut
7001 a Sánchez, Maria-Joseu Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain4 aut
7001 a Amiano, Pilaru Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastian, Spain4 aut
7001 a Chirlaque, María-Doloresu Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain4 aut
7001 a Guevara, Marcelau Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Instituto de Salud Pública y Laboral de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain4 aut
7001 a Sund, Malinu Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Department of Surgery, University of Helsinki & Helsinki University Hospital, Helsinki, Finland4 aut0 (Swepub:umu)masu0021
7001 a Bodén, Stinau Umeå universitet,Pediatrik4 aut0 (Swepub:umu)stabon98
7001 a Gunter, Marc J.u International Agency for Research on Cancer, World Health Organization, Lyon, France; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom4 aut
7001 a Gonzalez-Gil, Esther M.u International Agency for Research on Cancer, World Health Organization, Lyon, France4 aut
7001 a Weiderpass, Elisabeteu International Agency for Research on Cancer, World Health Organization, Lyon, France4 aut
7001 a Aguilera-Buenosvinos, Inmaculadau Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; International Agency for Research on Cancer, World Health Organization, Lyon, France; Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain4 aut
7001 a Tsilidis, Kostas K.u Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece4 aut
7001 a Heath, Alicia K.u Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom4 aut
7001 a Aune, Dagfinnu Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Department of Nutrition, Oslo New University College, Oslo, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital Ullevål, Oslo, Norway4 aut
7001 a Dossus, Laureu International Agency for Research on Cancer, World Health Organization, Lyon, France4 aut
7001 a Agudo, Antoniou Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain4 aut
7102 a Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spainb Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L’Hospitalet de Llobregat, Barcelona, Spain; Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain; Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States4 org
7730 t BMC Medicined : BioMed Central (BMC)g 21:1q 21:1x 1741-7015
8564 u https://doi.org/10.1186/s12916-023-02934-3y Fulltext
8564 u https://umu.diva-portal.org/smash/get/diva2:1782895/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-212072
8564 8u https://doi.org/10.1186/s12916-023-02934-3

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy